Open access · US-GOV via ClinicalTrials.gov Clinical trial

Brain Amyloid Imaging With Pittsburgh Compound B in Normal Aging, Mild Cognitive Impairment, and Dementia

Authors not listed

Mayo Clinic · 2008

Epigenetic alterations Human Randomized controlled trial

Abstract

This is a prospective, open label, non-therapeutic, diagnostic imaging study. The purpose of this study is to utilize Pittsburgh Compound B positron emission imaging (PiB PET) to ascertain the relationship between change in amyloid burden over time, and concurrent change in clinical status.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-21 MST

Cite this

APA

Anonymous. (2008). Brain Amyloid Imaging With Pittsburgh Compound B in Normal Aging, Mild Cognitive Impairment, and Dementia. <em>Mayo Clinic</em>. https://clinicaltrials.gov/study/NCT00950430

Vancouver

Anonymous. Brain Amyloid Imaging With Pittsburgh Compound B in Normal Aging, Mild Cognitive Impairment, and Dementia. Mayo Clinic. 2008.

BibTeX

@misc{anon2008BrainA, title = {Brain Amyloid Imaging With Pittsburgh Compound B in Normal Aging, Mild Cognitive Impairment, and Dementia}, author = {Anonymous}, journal = {Mayo Clinic}, year = {2008}, }